Brain Mapping & Therapeutics
Imaging, connectivity, and image-guided intervention
[ Brain, Spine and Mental Health ]
Neuroscience20 (N20) is the global policy summit convening leaders in brain, spine, and mental health across G20 nations. Launched in 2014 by the Society for Brain Mapping & Therapeutics, N20 aligns with the United States’ BRAIN Initiative and ongoing mental health policy agenda to accelerate the translation of neurotechnology into clinical practice.
The summit brings together policymakers, scientists, engineers, physicians, surgeons, universities, investors, and globally recognized research institutions to advance the development and deployment of clinical solutions for neurological disorders — conditions that affect more than three billion people and cost the global economy hundreds of billions of dollars annually.
Hosted by SBMT, the world’s leading authority in translational neurotechnology.
The 13th Annual N20 Summit convenes evidence-based discussion across the full clinical and translational spectrum of neuroscience. Sessions are structured around the policy, research, and clinical-deployment challenges that define the global brain-health agenda.
Imaging, connectivity, and image-guided intervention
The pipeline from lab to clinic, and the capital that moves it
AI for diagnosis, imaging, and therapeutic decision support
Structural and functional imaging at clinical scale
Stroke, aneurysm, and cerebrovascular intervention
Brain tumor diagnosis, surgery, and combination therapy
Depression, anxiety, and major mental illness at scale
Post-traumatic stress across civilian and military populations
Risk stratification, intervention, and policy frameworks
The ongoing pandemic and neurobehavioral interventions
Surgical, pharmacologic, and device-based approaches
Spinal disease, intervention, and rehabilitation
MS, ALS, Parkinson’s, and Alzheimer’s research
Acute care, rehabilitation, and long-term outcomes
Restoration, neuroprosthetics, and rehabilitation
FDA, EMA, and cross-border neurotechnology policy
The N20 Summit has convened across G20 capitals since 2014, driving cross-border policy alignment and translational research collaboration. Miami marks the 13th annual summit and the second U.S. host city in the program’s history.
Aligning with the Neuroscience20 Summit positions your organization at the global intersection of neurotechnology, policy, and clinical practice. Four anchors define what partnership delivers.
Position your organization among the world’s leading neuroscience and healthcare innovators, in front of policymakers and clinical decision-makers across G20 nations.
Build long-term relationships with clinicians, researchers, industry leaders, and policymakers shaping the future of brain, spine, and mental health.
Showcase your work in neurotechnology, AI, and therapeutic advancement to the audience that translates breakthroughs into clinical practice.
Engage directly with the global leaders shaping policy frameworks, regulatory pathways, and research funding for brain health.
Each tier delivers structured access and visibility appropriate to the level of engagement. All sales are final; payment is due within 30 days of invoice.
Prices shown are net. A processing fee (approximately 3%) is applied at checkout. Acceptance of participation and exhibition is at the discretion of the Symposium. All sales are final. Payment due within 30 days of invoice.
Premium partnership opportunities are limited. Direct conversations with SBMT leadership are reserved for organizations seeking visibility at the keynote, panel, and policy-program level. To open this conversation, contact Dr. Babak Kateb.
Request a partnership conversationSubmit your inquiry below. A member of the SBMT team will respond within two business days to confirm details and next steps. For immediate questions, contact Dr. Babak Kateb directly at babak.kateb@worldbrainmapping.org.